High-throughput tyrosine kinase activity profiling identifies FAK as a candidate therapeutic target in Ewing sarcoma.
暂无分享，去创建一个
M. Rivera | M. Fleming | B. Crompton | K. Stegmaier | A. Thorner | Jinyan Du | A. Christie | A. Kung | N. Kohl | M. Calicchio | Anne L Carlton